Predictors of reexcision findings and recurrence after breast conservation

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 4, 2003, Pages 979-985

  Smitt, Melanie C ^a,c   Nowels, Kent ^b   Carlson, Robert W ^b   Jeffrey, Stefanie S ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast; Margins; Radiotherapy

Indexed keywords

CHEMOTHERAPY; PATHOLOGY; RADIOTHERAPY;

RESIDUAL DISEASES;

ONCOLOGY;

ANTHRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0142186668     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00740-5     Document Type: Article

References (23)

1. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 333:1995;1444-1455.
2. Fisher E.R., Anderson S., Tan-Chiu E., et al. Fifteen-year prognostic discriminants for invasive breast carcinoma. Cancer. 91:2001;1679-1687.
3. Borger J., Kemperman H., Hart A., et al. Risk factors in breast conservation therapy. J Clin Oncol. 12:1994;653-660.
4. Clark R.M., McCullough P.B., Levine M.N., et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 84:1992;683-689.
5. Kurtz J.M. Factors influencing the risk of local recurrence in the breast. Eur J Cancer. 28:1992;660-666.
6. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer Influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 18:2000;1668-1675.
7. Petersen M.E., Schultz D.J., Reynolds C., et al. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 43:1999;1029-1035.
8. Wazer D.E., Schmidt-Ullrich R.K., Ruthazer R., et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 40:1998;851-858.
9. Freedman G., Fowble B., Hanlon A., et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Physics. 44:1999;1005-1015.
10. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 8:1990;113-118.
11. Vicini F.A., Eberlein T.J., Connolly J.L., et al. The optimal extent of resection for patients with stage I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg. 214:1991;200-204.
12. Fisher B., Costantino J., Redmond C., et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 320:1989;479-484.
13. Fisher B., Redmond C., Dimitrov N.V., et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 320:1989;473-478.
14. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 345:2001;1378-1387.
15. Romestaig P., Lehingue Y., Carrie C., et al. Role of a 10 Gy boost in the conservative treatment of early breast cancer Results of a randomized clinical trial in Lyon, France. J Clin Oncol. 15:1997;963-968.
16. Smitt M.C., Nowels K.W., Zdeblick M.J., et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer. 76:1995;259-267.
17. Recht A., Come S., Henderson I.C., et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early breast cancer. N Engl J Med. 334:1996;1356-1361.
18. Bellon J., Come S.E., Gelman R., et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer Updated results of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 51:(Suppl. 1):2001;2-3.
19. Wallgren A, Bernier J, Gelber RD, et al. Timing of radiotherapy and chemotherapy following breast conserving surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys;35:649-659.
20. Buchholz T.A., Tucker S.L., Erwin J., et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol. 19:2001;2240-2246.
21. Touboul E, Buffat L, Belkacemi Y. et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999;46:683-684.
22. Cowen D, Houvenaeghel G, Bardou V, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 2000;47:305-312.
23. DiBasie SJ, Komarnicky LT, Heron DE, et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phys 2002;53:680-686.